Correlation Between Pharvaris and Protect Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Protect Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Protect Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Protect Pharmaceutical, you can compare the effects of market volatilities on Pharvaris and Protect Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Protect Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Protect Pharmaceutical.

Diversification Opportunities for Pharvaris and Protect Pharmaceutical

-0.41
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pharvaris and Protect is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Protect Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Protect Pharmaceutical and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Protect Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Protect Pharmaceutical has no effect on the direction of Pharvaris i.e., Pharvaris and Protect Pharmaceutical go up and down completely randomly.

Pair Corralation between Pharvaris and Protect Pharmaceutical

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Protect Pharmaceutical. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 1.64 times less risky than Protect Pharmaceutical. The stock trades about -0.17 of its potential returns per unit of risk. The Protect Pharmaceutical is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  100.00  in Protect Pharmaceutical on September 4, 2024 and sell it today you would lose (20.00) from holding Protect Pharmaceutical or give up 20.0% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Protect Pharmaceutical

 Performance 
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pharvaris BV are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, Pharvaris unveiled solid returns over the last few months and may actually be approaching a breakup point.
Protect Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Protect Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pharvaris and Protect Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pharvaris and Protect Pharmaceutical

The main advantage of trading using opposite Pharvaris and Protect Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Protect Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Protect Pharmaceutical will offset losses from the drop in Protect Pharmaceutical's long position.
The idea behind Pharvaris BV and Protect Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes